IE40043B1 - 16,17,18,19,20-pentanorprostaglandins - Google Patents

16,17,18,19,20-pentanorprostaglandins

Info

Publication number
IE40043B1
IE40043B1 IE2014/73A IE201473A IE40043B1 IE 40043 B1 IE40043 B1 IE 40043B1 IE 2014/73 A IE2014/73 A IE 2014/73A IE 201473 A IE201473 A IE 201473A IE 40043 B1 IE40043 B1 IE 40043B1
Authority
IE
Ireland
Prior art keywords
trans
dimethylisopropylsilyloxy
pentanor
indanyl
cis
Prior art date
Application number
IE2014/73A
Other versions
IE40043L (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IE101/77A priority Critical patent/IE40044B1/en
Priority to IE102/77A priority patent/IE40045B1/en
Publication of IE40043L publication Critical patent/IE40043L/en
Publication of IE40043B1 publication Critical patent/IE40043B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/315Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

1456838 Silylated prostaglandins PFIZER Inc 8 Nov 1973 [8 Nov 1972] 51997/73 Heading C3S [Also in Division C2] N - Methansulphonyl - 15 - (5,6 - dimethoxy- 2 - indanyl) - 9α,11α,15# - tris - (dimethylisopropylsilyloxy) - 16,17,18,19,20 - pentanor - 13 - trans-prostenamide is prepared by hydrogenating N-methanesulphonyl-15-(5,6-dimethoxy-2- indanyl) - 9α,11α,15# - tris - (dimethylisopropylsilyloxy) - 16,17,18,19,20 - pentanor - 5 - cis, 13- trans-prostadienamide, resulting from the reaction between dimethylisopropylchlorosilane and N - methanesulphonyl - 9α,11α,15# - trihydroxy - 16,17,18,19,20 - pentanor - 5 - cis, 13- trans - prostadienamide. 16 - (2 - Indonyl)- 11α,15α - bis - (dimethylisopropylsilyloxy) - 9- oxo - 17,18,19,20 - tetranor - 13 - trans - prostenoic acid and 16-(2-indanyl)-11α,15α-bis-(dimethylisopropylsilyloxy) - 9 - oxo - 17,18.19,20- tetranor-5-cis, 13-trans-prostadienoic acid are obtained in a similar manner. [GB1456838A]
IE2014/73A 1972-11-08 1973-11-08 16,17,18,19,20-pentanorprostaglandins IE40043B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IE101/77A IE40044B1 (en) 1972-11-08 1973-11-08 Cyclopentane derivatives
IE102/77A IE40045B1 (en) 1972-11-08 1973-11-08 Substituted dimethyl oxophosphonates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08

Publications (2)

Publication Number Publication Date
IE40043L IE40043L (en) 1974-05-08
IE40043B1 true IE40043B1 (en) 1979-02-28

Family

ID=23177829

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2014/73A IE40043B1 (en) 1972-11-08 1973-11-08 16,17,18,19,20-pentanorprostaglandins

Country Status (20)

Country Link
JP (1) JPS5714347B2 (en)
AT (1) AT345999B (en)
BE (1) BE807046A (en)
CA (1) CA1033727A (en)
CH (1) CH593930A5 (en)
DE (1) DE2355731C3 (en)
DK (1) DK143499C (en)
ES (3) ES420386A1 (en)
FI (1) FI58912C (en)
FR (3) FR2205338B1 (en)
GB (1) GB1456838A (en)
IE (1) IE40043B1 (en)
IL (2) IL50310A (en)
IN (1) IN139265B (en)
NL (1) NL7315307A (en)
NO (2) NO143663C (en)
PH (2) PH13261A (en)
SE (4) SE412229B (en)
SU (2) SU667131A3 (en)
ZA (1) ZA738595B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
JPS5823393B2 (en) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ prostaglandin
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
NZ183136A (en) * 1976-02-11 1978-11-13 Miles Lab Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
US4074063A (en) * 1976-02-11 1978-02-14 Miles Laboratories, Inc. Bicycloalkyl derivatives of prostaglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
DE2753995A1 (en) * 1977-12-03 1979-06-07 Bayer Ag NEW BICYCLOALKENYL PROSTAGLANDINS AND THE METHOD OF MANUFACTURING THEM
ATE270660T1 (en) * 1997-09-09 2004-07-15 Univ Duke AROMATIC C16-C20-SUBSTITUTED TETRAHYDRO-PROSTAGLANDINS USABLE LIKE FP AGONISTS
AU741014B2 (en) * 1997-09-09 2001-11-22 Duke University Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
ATE227266T1 (en) * 1997-09-09 2002-11-15 Procter & Gamble AROMATIC C16-C20-SUBSTITUTED TETRAHYDRO-PROSTAGLANDINS AND THEIR USE AS PROSTAGLANDIN F AGONISTS
CA2364948C (en) 1999-03-05 2011-04-26 The Procter & Gamble Company C16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
DE502007000840D1 (en) * 2007-11-28 2009-07-16 Bauer Maschinen Gmbh winch
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20230097470A1 (en) * 2021-08-23 2023-03-30 Chirogate International Inc. Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (en) * 1971-04-30 1973-09-05

Also Published As

Publication number Publication date
FI58912B (en) 1981-01-30
NO144385C (en) 1981-08-19
NO143663B (en) 1980-12-15
SU704456A3 (en) 1979-12-15
DK143499C (en) 1982-01-11
NO743616L (en) 1974-05-09
NO143663C (en) 1981-03-25
IE40043L (en) 1974-05-08
ZA738595B (en) 1974-09-25
IL43571A (en) 1977-08-31
ES444398A1 (en) 1977-12-01
PH13261A (en) 1980-02-25
FR2205338A1 (en) 1974-05-31
SE412229B (en) 1980-02-25
IN139265B (en) 1976-05-29
SE7701523L (en) 1977-02-10
JPS49133357A (en) 1974-12-21
PH13320A (en) 1980-03-13
ES420386A1 (en) 1976-07-01
DE2355731B2 (en) 1980-04-30
BE807046A (en) 1974-05-08
IL50310A (en) 1977-08-31
DE2355731C3 (en) 1981-01-15
FR2205338B1 (en) 1978-07-13
CH593930A5 (en) 1977-12-30
JPS5714347B2 (en) 1982-03-24
FR2291200A1 (en) 1976-06-11
CA1033727A (en) 1978-06-27
ES456279A1 (en) 1978-11-01
NL7315307A (en) 1974-05-10
AT345999B (en) 1978-10-10
FR2291200B1 (en) 1979-01-05
ATA941073A (en) 1978-02-15
FR2286147A1 (en) 1976-04-23
DK143499B (en) 1981-08-31
FR2286147B1 (en) 1978-09-22
SU667131A3 (en) 1979-06-05
NO144385B (en) 1981-05-11
FI58912C (en) 1981-05-11
AU6230273A (en) 1975-05-08
SE7612261L (en) 1976-11-03
DE2355731A1 (en) 1974-05-22
IL43571A0 (en) 1974-03-14
SE7612262L (en) 1976-11-03
GB1456838A (en) 1976-11-24
SE417957B (en) 1981-04-27

Similar Documents

Publication Publication Date Title
IE40043B1 (en) 16,17,18,19,20-pentanorprostaglandins
GB1409841A (en) Prostaglandins and the manufacture thereof
GB1448413A (en) Prostaglandins and the manufacture therof
AU468059B2 (en) Mutanase, an alpha-1, 3-glucanese, a process forthe preparation thereof aswell ascertain uses ofthe said mutanese
ES444045A1 (en) Prostanoic acid derivatives
CA1018171A (en) SUBSTITUTED .alpha.-AMINOOXYCARBOXYLIC ACID HYDRAZIDE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF
IE37909B1 (en) 15-substituted-omega-pentanorprostaglandins
CA1031374A (en) Manufacture of 1,6-hexanediol
CA1014490A (en) Light-weight, flexible, easy-open, impermeable package system
CA1028699A (en) Prostanoic acid derivatives
AU473283B2 (en) 8,12 prostaglandin analogues
IE41600L (en) 3, 4 - dihydro - 2h - isoquinolin - 1 - thiones
CA1033752A (en) 2,3-disubstituted 7-oxabicyclo-(2.2.1)-5-heptene derivatives
GB1450425A (en) Process for the manufacture of beta-3-oxo-7alpha-acetylthio- 17beta-hydroxy-4-androsten-17alpha-yl- -propionic acid ypsilon- lactone and an intermediate in its production
IE40177L (en) D-homopregnenes.
CA967565A (en) Selective reduction of 9,15-diketo prostaglandins
IE37977B1 (en) Norbornane derivatives
CA968792A (en) Stereospecific reduction of 9,15-diketo prostaglandins
GB1397431A (en) Insecticidal steroid
CA1028352A (en) PREPARATION OF .alpha.,3-DICHLORO-4-CYCLOHEXYLPHENYL-ACETIC ACID
CA1028351A (en) PREPARATION OF .alpha.,3-DICHLORO-4-CYCLOHEXYLPHENYL-ACETIC ACID
IE40108B1 (en) Substituted s-triazino-(1,2)-benzimidazoles and their manufacture
IE39500L (en) Citric acid production and intermediate therefor.
CA1022183A (en) 1,4-diacyloxy-2,3-butanediol and a method for its producing
AU485558B2 (en) N, n'disubstituted naphthaleneacetamidines